World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
42123
World Ranking
16882
National Ranking
8465

Overview

Nicholas J. Petrelli is affiliated with Christiana Care Health System in the United States. Their research primarily focuses on various aspects of oncology, surgery, and medicine, particularly related to cancer treatments and outcomes.

The scientist's recent publications demonstrate a focus on clinical outcomes and treatment efficacy across several cancer types and surgical methods. Notable papers include:

  • Pancreatic resections: 30 and 90-day outcomes in octogenarians, 2020, Surgical Oncology
  • Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula, 2020, The American Surgeon
  • Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer, 2024, Journal of Clinical Oncology
  • A Comparison of Colectomy Outcomes Utilizing Open, Laparoscopic, and Robotic Techniques, 2020, The American Surgeon
  • Microbiome and colorectal cancer: A review of the past, present, and future, 2021, Surgical Oncology

Their frequent co-authors include:

  • Michael Johns
  • Gregory Tiesi
  • Carmen J. Allegra
  • William T. Merritt
  • Greg Yothers

Common publication venues for their work encompass:

  • Surgical Oncology
  • Journal of Clinical Oncology
  • UNC Libraries
  • The American Surgeon
  • Journal of the American College of Surgeons

The main field of study is Medicine, with subfields including Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine, and Public Health, Environmental and Occupational Health.

Primary research topics covered are:

  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Gastric Cancer Management and Outcomes
  • Pancreatitis Pathology and Treatment
  • Gallbladder and Bile Duct Disorders
  • Colorectal Cancer Surgical Treatments
  • Sarcoma Diagnosis and Treatment

Best Publications

  • Comprehensive molecular portraits of human breast tumours

    Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt

  • Comprehensive molecular characterization of human colon and rectal cancer

    Donna M. Muzny;Matthew N. Bainbridge;Kyle Chang;Huyen H. Dinh

  • Comprehensive genomic characterization of squamous cell lung cancers

    Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Guidelines 2000 for Colon and Rectal Cancer Surgery

    Heidi Nelson;Nicholas Petrelli;Arthur Carlin;Jean Couture

  • Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

    Joseph F. Costello;Joseph F. Costello;Michael C. Frühwald;Michael C. Frühwald;Dominic J. Smiraglia;Laura J. Rush

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

  • Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

    M Flam;M John;T F Pajak;N Petrelli

  • Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

    W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton

  • Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

    J. Philip Kuebler;H. Samuel Wieand;Michael J. O'Connell;Roy E. Smith

  • Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

    Mark S. Roh;Linda H. Colangelo;Michael J. O'Connell;Greg Yothers

  • The Benefit of Leucovorin-Modulated Fluorouracil as Postoperative Adjuvant Therapy for Primary Colon Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-03

    N Wolmark;H Rockette;B Fisher;D L Wickerham

  • The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.

    N Petrelli;H O Douglass;L Herrera;D Russell

  • Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline

    Christopher E. Desch;Al B. Benson;Mark R. Somerfield;Patrick J. Flynn

  • Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

    Greg Yothers;Michael J. O'Connell;Carmen J. Allegra;J. Philip Kuebler

  • Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

    Carmen J. Allegra;Greg Yothers;Michael J. O'Connell;Saima Sharif

  • Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02

    Norman Wolmark;H. Samuel Wieand;David M. Hyams;Linda Colangelo

  • A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.

    N Petrelli;L Herrera;Y Rustum;P Burke

  • The onset and extent of genomic instability in sporadic colorectal tumor progression

    Daniel L. Stoler;Neng Chen;Mark Basik;Morton S. Kahlenberg

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

Frequent Co-Authors

Miguel A. Rodriguez-Bigas
Miguel A. Rodriguez-Bigas The University of Texas MD Anderson Cancer Center
Mary C. Farach-Carson
Mary C. Farach-Carson The University of Texas Health Science Center at Houston
David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Mark R. Somerfield
Mark R. Somerfield American Society of Clinical Oncology
Norman Wolmark
Norman Wolmark University of Pittsburgh
Zuo-Feng Zhang
Zuo-Feng Zhang University of California, Los Angeles
James R. Marshall
James R. Marshall Roswell Park Cancer Institute
Richard B. Bankert
Richard B. Bankert University at Buffalo, State University of New York
Bernard Fisher
Bernard Fisher University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are thinking about studying Medicine in the USA, there are a variety of alternative healthcare degrees that can open rewarding career paths. Many students interested in medicine pursue nursing, mental health, or healthcare administration—fields that offer flexible online learning options.

For those wanting to enter the medical workforce quickly, accelerated lpn programs help you become a Licensed Practical Nurse in less time. If your interest lies in mental health, you might consider the fastest pmhnp program, which allows registered nurses to quickly advance into specialized psychiatric-mental health roles.

Healthcare administrators are always in demand, and affordable online options make this a popular avenue. Explore the cheapest mha programs online or the most affordable online mha programs to gain management knowledge at a lower cost. Each provides flexibility for students managing work or family commitments, making a healthcare career more accessible than ever.

Best Scientists Citing Nicholas J. Petrelli

Trending Scientists